NASOVA EAR DRYING DROPS- isopropyl alcohol 95% solution/ drops 
Innovus Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Nasova Ear Drying Drops

Active ingredients

Isopropyl alcohol 95% in an anhydrous glycerin base

Purpose

Ear drying aid

Uses

Dries water in the ears and relieves water-clogged ears

Warnings

Flammable: Keep away form fire or flame

Do not use

in the eyes

Aslk a doctor before use if you have

Stop use and ask a doctor if

Irritation (too much burning) or pain occurs

Keep out of reach of children 

In case of accidental ingestion, seek professional assistant or contact a Poison Control Center immediately.

Directions

Other Information 

Inactive ingredients

Glycerin

Questions?

Call 1.800.996.5122 (Mon-Fri 9AM-5PM EST)

image description

NASOVA EAR DRYING DROPS 
isopropyl alcohol 95% solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57483-350
Route of AdministrationAURICULAR (OTIC)
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302) ISOPROPYL ALCOHOL950 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57483-350-152 in 1 CARTON11/02/2021
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34411/02/2021
Labeler - Innovus Pharmaceuticals, Inc. (962507187)
Establishment
NameAddressID/FEIBusiness Operations
AMMAN PHARMACEUTICAL INDUSTRIES534677849manufacture(57483-350)

Revised: 12/2022
Document Id: 52d10a0b-2bab-4a99-b6e0-a57aa780b066
Set id: ddb9359e-2fc4-4ce3-a7d2-027b17f01161
Version: 2
Effective Time: 20221231
 
Innovus Pharmaceuticals, Inc.